Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opgen Inc (OPGN)

Opgen Inc (OPGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 87,246
  • Shares Outstanding, K 38,266
  • Annual Sales, $ 4,210 K
  • Annual Income, $ -26,210 K
  • 60-Month Beta -0.44
  • Price/Sales 21.61
  • Price/Cash Flow N/A
  • Price/Book 2.75
Trade OPGN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +48.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.19 +4.11%
on 04/16/21
3.13 -27.16%
on 03/23/21
-0.66 (-22.45%)
since 03/19/21
3-Month
1.63 +39.88%
on 03/05/21
4.37 -47.83%
on 02/08/21
-0.01 (-0.44%)
since 01/21/21
52-Week
1.63 +39.88%
on 03/05/21
4.44 -48.65%
on 08/07/20
+0.03 (+1.33%)
since 04/21/20

Most Recent Stories

More News
OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections

OpGen, Inc. (Nasdaq: OPGN) announced today that its strategic collaboration with the New York State Department of Health ("DOH") to develop a state-of-the-art solution to detect, track, and manage antimicrobial-resistant...

OPGN : 2.25 (-1.32%)
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients

Experts presented the results of their Unyvero studies and demonstrated:

OPGN : 2.25 (-1.32%)
OpGen, Inc. (OPGN) Reports Q4 Loss, Tops Revenue Estimates (Revised)

OpGen, Inc. (OPGN) delivered earnings and revenue surprises of -20.69% and 4.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OPGN : 2.25 (-1.32%)
OpGen, Inc. (OPGN) Reports Q4 Loss, Tops Revenue Estimates

OpGen, Inc. (OPGN) delivered earnings and revenue surprises of -6.90% and 4.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OPGN : 2.25 (-1.32%)
OpGen Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

-- Total combined pro-forma revenue for 2020 was approximately $5.2 million

OPGN : 2.25 (-1.32%)
OpGen, Inc. (OPGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

OpGen, Inc. (OPGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OPGN : 2.25 (-1.32%)
Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT.

BNGO : 5.26 (-2.23%)
SINT : 1.3300 (-1.50%)
OPGN : 2.25 (-1.32%)
GME : 160.38 (+1.17%)
JNJ : 165.67 (-0.49%)
Thinking about buying stock in Inovalon Holdings, OpGen, Shift Technologies, Surface Oncology, or Aytu Bioscience?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INOV, OPGN, SFT, SURF, and AYTU.

INOV : 29.09 (-1.42%)
SFT : 6.93 (-0.14%)
SURF : 6.46 (+0.16%)
AYTU : 6.31 (-2.02%)
OPGN : 2.25 (-1.32%)
Thinking about buying stock in OpGen, XpresSpa, Jaguar Health, Orchard Therapeutics, or Novan?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, XSPA, JAGX, ORTX, and NOVN.

NOVN : 1.0700 (+1.90%)
ORTX : 5.67 (-1.39%)
XSPA : 1.2600 (+1.61%)
JAGX : 1.2250 (-1.21%)
OPGN : 2.25 (-1.32%)
OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia

Karolinska Institutet Study highlights Unyvero HPN demonstrating a higher diagnostic yield than bacterial culture, enabling rapid diagnosis of pathogens of concern in these patients

OPGN : 2.25 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.

See More

Key Turning Points

3rd Resistance Point 2.49
2nd Resistance Point 2.43
1st Resistance Point 2.35
Last Price 2.25
1st Support Level 2.21
2nd Support Level 2.15
3rd Support Level 2.08

See More

52-Week High 4.44
Fibonacci 61.8% 3.37
Fibonacci 50% 3.04
Fibonacci 38.2% 2.70
Last Price 2.25
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar